Latest filing published 15 Dec 2025 for Amphastar Pharmaceuticals, Inc., €38k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Floyd F. Petersen in Amphastar Pharmaceuticals, Inc., where the filings describe the role as board member. Between 9 June 2016 and 12 December 2025, the trades on record add up to 100 filings.
No open-market purchase appears, only 80 sales worth €3.9M. The rest of the record consists of 10 share grants and 9 option exercises. Since January 2025: no purchases and 12 sales on the market.
The newest entry dates from 15 December 2025: an open-market sale of €54k, in Amphastar Pharmaceuticals, Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 45 declarations